Skip to main content
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. — Investor Relations & Filings

Ticker · ANIK ISIN · US0352551081 LEI · 529900R9LS3Z0O6QH455 US Manufacturing
Filings indexed 1,010 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country US United States of America
Listing US ANIK

About Anika Therapeutics, Inc.

https://anika.com/

Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.

Recent filings

Filing Released Lang Actions
8-K - Anika Therapeutics, Inc. (0000898437) (Filer)
Regulatory Filings
2026-04-29 English
4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
Director's Dealing
2026-03-23 English
4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
Director's Dealing
2026-03-18 English
4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
Director's Dealing
2026-03-18 English
4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
Director's Dealing
2026-03-18 English
4 - Anika Therapeutics, Inc. (0000898437) (Issuer)
Director's Dealing
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.